All Infection Prevention & Control articles – Page 11
-
NewsDisarming a hidden killer: Predicting – and preventing – C. diff before it strikes
Researchers have developed a powerful, personalized modeling framework to predict whether Clostridioides difficile is likely to colonize an individual’s gut, and to test whether specific probiotic therapies might prevent and/or reverse that colonization.
-
NewsM42 announces breakthrough results for its AI-powered tuberculosis screening
A new study is among the largest real-world clinical validations of an AI-driven healthcare solution to date, analyzing over one million chest X-rays (CXRs) to evaluate the efficacy and scalability of AI in TB screening.
-
NewsNew drug combo outperforms Tamiflu in fighting flu (and chocolate is the key)
Scientists have unveiled a new drug pairing - including a compound found in chocolate - that outperforms Tamiflu, the most widely used anti-influenza medication, against even the deadliest flu strains, including avian and swine flu.
-
NewsStudy finds gaps in evidence for air cleaning technologies designed to prevent respiratory infections
A new study finds that although many technologies claim to clean indoor air and prevent the spread of viruses like COVID-19 and the flu, most have not been tested on people and their potential risks are not yet fully understood.
-
NewsRegional differences in antibiotic use in newborns
There are relatively large regional differences in Sweden in the proportion of newborns receiving antibiotics for suspected sepsis, according to a study. The researchers want to call attention to overuse as well as highlight good examples.
-
NewsResearchers debunk long-standing concern about flu treatment in children
Researchers have debunked a long-standing theory about oseltamivir, known as Tamiflu. Oseltamivir treatment during flu episodes was associated with a reduced risk of serious neuropsychiatric events, such as seizures, altered mental status and hallucination.
-
NewsBacterial signaling molecule that choreographs flip between biofilm and motility could transform biotechnology and medical applications
A bacterial signaling molecule involved in flipping the switch between sessile and motile forms could offer huge potential in improving probiotics, boosting wastewater treatment and producing therapeutic compounds.
-
NewsNew mega RNA virus may hold the key to mass oyster die-offs
Scientists have discovered a previously unknown virus in farmed Pacific oysters during a mass die-off in B.C., Canada. The discovery serves as a reminder that growers should exercise caution when moving young oysters, to prevent potential spread of pathogens.
-
NewsSmart wound monitor poised to improve chronic infection care
Researchers have developed a wearable wound monitoring device with integrated sensors that could reduce infection risks by minimising the need for frequent physical contact.
-
NewsScientists discover how leukemia virus stays hidden in the body
A research team has discovered how the human T-cell leukemia virus type 1 (HTLV-1) silently persists in the body. Their findings identify a previously unknown genetic “silencer” element that keeps the virus in a dormant, undetectable state.
-
NewsStatistical modeling can help tackle neglected tropical diseases among migrant populations
A study of migrants in Italy has shown how statistical modelling can help improve the identification of Neglected Tropical Disease (NTD) infections.
-
NewsSkin test reagent proves effective and safe for TB diagnosis in children
A new class of skin test reagents based on Mycobacterium tuberculosis (MTB)-specific antigens has been developed. A phase III clinical trial suggests that C-TST is an effective and safe option for diagnosing pediatric TBI.
-
NewsResearchers develop bacterial cellulose-based dressing for advanced burn wound care
Scientists have developed an innovative bacterial cellulose (BC)-based hemostatic dressing that enables rapid and sustained bleeding control.
-
NewsScientists pinpoint optimal dose of methylprednisolone for treating severe Mycoplasma pneumoniae pneumonia
Investigators have compared the efficacy of low- versus high-dose of methylprednisolone in preventing pulmonary lesions in children with severe Mycoplasma pneumoniae pneumonia.
-
NewsNew farmer-led research project explores how badger vaccination may be used within TB eradication strategy
A progressive new UK project is underway to explore the contribution, effectiveness and practicality of professionally scaled-up, industry delivered badger vaccination as part of a comprehensive TB eradication strategy.
-
NewsImmunoglobulin replacement therapy shows no reduction in serious infections for patients with CLL
In patients with chronic lymphocytic leukemia (CLL), regular treatment with immunoglobulin replacement therapy was not associated with a reduced risk of serious infections requiring hospitalization, according to a study published in Blood Advances.
-
NewsLarge study uncovers specific impacts of flooding on older adult health
New research examining 17 years of data from Medicare hospitalization claims and major flooding events finds increased rates of skin diseases, nervous system diseases, and injuries or poisonings among adults aged 65 and older following major floods.
-
NewsGene therapy may block HIV transmission during breastfeeding, study shows
Delivering broadly neutralizing antibodies against HIV-1 to newborns via gene therapy provided them with multi-year protection from HIV/AIDS infection, according to an animal study.
-
NewsStudy highlights the severity of acute necrotizing encephalopathy in kids with the flu
For a small subset of children, influenza can trigger a rare but serious complication called influenza-associated acute necrotizing encephalopathy (ANE). Now, findings of a multicenter study suggest that ANE is often fatal in these children — despite intensive treatment.
-
NewsClinical trial finds safe, effective treatment for children with severe post-Covid syndrome
Researchers have discovered that a drug designed to treat Celiac disease supported a more rapid return to normal activities for patients following COVID. A small, randomized clinical trialfound the oral drug larazotide was both safe and effective in treating children with MIS-C.